WO2012119605A1 - New disperse dye with potent anticancer activity - Google Patents
New disperse dye with potent anticancer activity Download PDFInfo
- Publication number
- WO2012119605A1 WO2012119605A1 PCT/EG2011/000002 EG2011000002W WO2012119605A1 WO 2012119605 A1 WO2012119605 A1 WO 2012119605A1 EG 2011000002 W EG2011000002 W EG 2011000002W WO 2012119605 A1 WO2012119605 A1 WO 2012119605A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- disperse dye
- anticancer activity
- potent anticancer
- new
- new disperse
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Definitions
- 2-cinnamyl-5,6,7,8-tetrahydro[l ]benzothieno[2,3-d )pyrimidine- 4(3H)-one is a yellow powder of new synthesized disperse dye which synthesized by reacting2-amino-4,5,6,7-tetrahydrobenzo[bjthiophene-3- carboxamide with cinnamaldehyde in presence of HCL(few drops) and filtered after 5 hours and filtrate is recrystallized from methanol then the powder is subjected to anticancer activity at the national cancer institute at different cell lines showing a potent anticancer activity.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
New yellow disperse dye of 2-cinnamyl-5,6,7,8- tetrahydro[l]benzothieno[2,3-d]pyrimidine-4(3H)-one with a first medical application as anticancer showing potent activity against different cancer cell lines and low cytotoxicity to melanocytes (normal skin) which will be helpful in treatment of cancer specially melanoma due to dye stability on the skin.
Description
NEW DISPERSE DYE WITH POTENT
ANTICANCER ACTIVITY
Technical Field:
Treatment of cancer specially melanoma due to dye stability.
Background Art:
All disperse dyes was only used in polyester dyeing but no medical use.
Disclosure of Invention:
2-cinnamyl-5,6,7,8-tetrahydro[l ]benzothieno[2,3-d )pyrimidine- 4(3H)-one is a yellow powder of new synthesized disperse dye which synthesized by reacting2-amino-4,5,6,7-tetrahydrobenzo[bjthiophene-3- carboxamide with cinnamaldehyde in presence of HCL(few drops) and filtered after 5 hours and filtrate is recrystallized from methanol then the powder is subjected to anticancer activity at the national cancer institute at different cell lines showing a potent anticancer activity.
Claims
1. First medical application for disperse dye as anticancer.
2. New compound of yellow disperse dye.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EG2011/000002 WO2012119605A1 (en) | 2011-03-10 | 2011-03-10 | New disperse dye with potent anticancer activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EG2011/000002 WO2012119605A1 (en) | 2011-03-10 | 2011-03-10 | New disperse dye with potent anticancer activity |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2012119605A1 true WO2012119605A1 (en) | 2012-09-13 |
Family
ID=44625918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EG2011/000002 WO2012119605A1 (en) | 2011-03-10 | 2011-03-10 | New disperse dye with potent anticancer activity |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012119605A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016191537A1 (en) * | 2015-05-28 | 2016-12-01 | The Regents Of The University Of California | Tubulin-binding compounds, compositions and uses related thereto |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050032778A1 (en) * | 2003-06-10 | 2005-02-10 | Solvay Pharmaceuticals B.V. | Therapeutically active thiophenepyrimidinone compounds and their use |
US20050038053A1 (en) * | 2003-06-10 | 2005-02-17 | Solvay Pharmaceuticals B.V. | Novel compounds and their use in therapy |
US20050250794A1 (en) * | 2003-12-19 | 2005-11-10 | Andrew Napper | Methods of treating a disorder |
WO2006044826A2 (en) * | 2004-10-20 | 2006-04-27 | Compass Pharmaceuticals Llc | Thiophens and their use as anti-tumor agents |
US20090030196A1 (en) * | 2006-12-29 | 2009-01-29 | Abbott Laboratories | Pim kinase inhibitors as cancer chemotherapeutics |
-
2011
- 2011-03-10 WO PCT/EG2011/000002 patent/WO2012119605A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050032778A1 (en) * | 2003-06-10 | 2005-02-10 | Solvay Pharmaceuticals B.V. | Therapeutically active thiophenepyrimidinone compounds and their use |
US20050038053A1 (en) * | 2003-06-10 | 2005-02-17 | Solvay Pharmaceuticals B.V. | Novel compounds and their use in therapy |
US20050250794A1 (en) * | 2003-12-19 | 2005-11-10 | Andrew Napper | Methods of treating a disorder |
WO2006044826A2 (en) * | 2004-10-20 | 2006-04-27 | Compass Pharmaceuticals Llc | Thiophens and their use as anti-tumor agents |
US20090030196A1 (en) * | 2006-12-29 | 2009-01-29 | Abbott Laboratories | Pim kinase inhibitors as cancer chemotherapeutics |
Non-Patent Citations (2)
Title |
---|
PECH R ET AL: "UEBER THIENO-VERBINDUNGEN 7. MITTEILUNG: ZUR DARSTELLUNG VON 2-ARYLVINYL-3,4-DIHYDRO-4-OXOTHIENO Ä2,3-DÜPYRIMIDINEN//THIENO COMPOUNDS. PART 7. PREPARATION OF 2-(ARYLVINYL)-3,4-DIHYDRO-4-OXOTHI ENO Ä2,3-DÜPYRIMIDINES", DIE PHARMAZIE, GOVI VERLAG PHARMAZEUTISCHER VERLAG GMBH, ESCHBORN, DE, vol. 42, no. 2, 1 January 1987 (1987-01-01), pages 131, XP008047719, ISSN: 0031-7144 * |
SHISHOO C J ET AL: "STUDIES ON THE SYNTHESIS OF 2-(2-ARYLVINYL)THIENO not 2,3-D 3/4 PYRIMIDINESAND 5-(2-ARYLVINYL)TRIAZOLOTHIENOL not 3,2-E 3/4 PYRIMIDINES", JOURNAL OF HETEROCYCLIC CHEMISTRY, WILEY-BLACKWELL PUBLISHING, INC, US, vol. 22, no. 3, 1 May 1985 (1985-05-01), pages 825 - 830, XP000983905, ISSN: 0022-152X, DOI: 10.1002/JHET.5570220343 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016191537A1 (en) * | 2015-05-28 | 2016-12-01 | The Regents Of The University Of California | Tubulin-binding compounds, compositions and uses related thereto |
US10913750B2 (en) | 2015-05-28 | 2021-02-09 | The Regents Of The University Of California | Tubulin-binding compounds, compositions and uses related thereto |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012013713A3 (en) | Substituted imidazo[1,2-b]pyridazines | |
HK1251568A1 (en) | Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same | |
NZ609448A (en) | Tricyclic pi3k inhibitor compounds and methods of use | |
MX2009012144A (en) | Novel pyridopyrazine derivatives, process of manufacturing and uses thereof. | |
MY170878A (en) | [1,2,3] triazolo [4,5-d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 | |
UY35115A (en) | IMIDAZO [1,2-A] PIRIDINCARBOXAMIDS AMINOSUSTITUIDAS AND ITS USE | |
WO2014045162A8 (en) | ALKYL-SUBSTITUTED HEXAHYDROPYRANO[3,4-d] [1,3]THIAZIN-2-AMINE COMPOUNDS | |
MX2022007264A (en) | Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof. | |
PH12016500250B1 (en) | Novel triazolo [4,5-d] pyrimidine derivatives | |
PE20200725A1 (en) | CRYSTALLINE FORMS OF THE ANDROGEN RECEPTOR MODULATOR: 4- [7- (6-CYANE-5-TRIFLUOROMETHYLPYRIDIN-3-IL) -8-OXO-6-THIOXO-5,7-DIAZAESPIRO [3,4] OCT-5-IL ] -2-FLUORO-N-METHYLBENZAMIDE) (APALUTAMIDE) | |
AU2011288503A8 (en) | 6-Cycloalkyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as PDE9A inhibitors | |
NZ624068A (en) | Fused tricyclic compounds as raf kinase inhibitors | |
ECSP11011257A (en) | TRIAZOL DERIVATIVES [4,3-B] PIRIDAZINE AND ITS USES FOR PROSTATE CANCER | |
MX346248B (en) | [1, 2, 3]triazolo [4, 5 -d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 agonists. | |
WO2014040052A3 (en) | Glycyrrhetinic acid derivatives with anti-inflammatory activity | |
MX361157B (en) | Dioxino- and oxazin-[2,3-d]pyrimidine pi3k inhibitor compounds and methods of use. | |
WO2011077461A3 (en) | Disperse azo dyes | |
WO2013021260A3 (en) | Compounds from anisomeles heyneana | |
CO6460764A2 (en) | [1,2,4] TRIAZOLO [4,3-B] PIRIDAZINAS AS LIGANDS OF THE ANDROGEN RECEIVER | |
WO2014053968A8 (en) | Pyrrolo[3,2-c]pyridine tropomyosin-related kinase inhibitors | |
WO2012119605A1 (en) | New disperse dye with potent anticancer activity | |
NZ610939A (en) | Novel antifungal 5,6-dihydro-4h-pyrrolo[1,2-a][1,4]- benzodiazepines and 6h-pyrrolo[1,2-a][1,4]benzodiazepines substituted with bicyclic benzene derivatives | |
AR098762A1 (en) | 2- (4- (2- (1-ISOPROPIL-3-METHYL-1H-1,2,4-TRIAZOL-5-IL) -5,6-DIHYDROBENZO [F] IMIDAZO [1,2-D] [1,4] OXAZEPIN-9-IL) -1H-PIRAZOL-1-IL) -2-METHYLPROPANAMIDE, PRODUCTION METHODS, AND PHARMACEUTICAL USES OF THE SAME | |
WO2013103925A3 (en) | Liposomally encapsulated reduced glutathione for management of cancer with other uses and methods | |
WO2012021409A3 (en) | Anthraquinone Analogs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11715160 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11715160 Country of ref document: EP Kind code of ref document: A1 |